Compliance With Anticoagulants

Terminology and Definitions

ROCKET AF: Patients Off Study Drug Are at Increased Risk of Stroke and Non-CNS Embolism

Slight Benefit in First Year Post-Trial: No Harm or Benefit Years 2-5+

Features of NOACs

Dosing Considerations: Summary

Compliance to Therapy

Factors Related to Compliance

Compliance With OD vs BID Regimens Is Generally Better for

Chronic Conditions

Patient Enrollment

Antithrombotic Treatment According

to CHA2DS2-VASc Score

Antithrombotic Therapy According to

AF Clinical Presentation

Antithrombotic Therapy in AF: Real-World Clinical Characteristics in Japan

J-ROCKET AF: Principal Safety Outcome

Major or Non-Major Clinically Relevant Bleeding

J-ROCKET AF: Primary Efficacy End Point

Stroke and Non-CNS Systemic Embolism

NOACs: Agenda for Outpatient Visits

AEGEAN Study: Impact of Educational Program on Patient Adherence to Apixaban

Summary

Abbreviations

Abbreviations (cont)

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)